Human VEGF-A PharmaGenie ELISA Kit (SBRS1226)

This Assay Genie kit quantifies vascular endothelial growth factor A, a homodimeric glycoprotein central to angiogenesis, vascular permeability, and tumor neovascularization research. The immunoassay captures VEGF-A across plasma, lysate, and supernatant matrices using pre-coated microplate wells, with results read on a standard plate reader.

Quantitative performance supports studies in oncology, wound healing, ophthalmology, and cardiovascular disease, where VEGF-A serves as both a biomarker and a therapeutic target for anti-angiogenic interventions. Each kit provides reagents sufficient for 96 determinations and includes a recombinant VEGF-A standard curve covering 31.25 to 2000 pg/mL, with an analytical sensitivity below 15.6 pg/mL and a 100 uL recommended sample volume per well.

Intended for research use only and not for diagnostic procedures, the reagents are supplied ready-to-use where possible and require storage at 4 degrees C with the standard kept frozen at -20 degrees C until first use. Researchers investigating bevacizumab response, diabetic retinopathy models, or tumor microenvironment cytokine profiling will find the assay compatible with standard laboratory workflows.